Home
About
FAQ
History (24)
Change in Age-Specific, Psychosocial Correlates of Risky Sexual Behaviors Among Youth: Longitudinal Findings From a Deep South, High-Risk Sample.
Randomized phase II trial of docetaxel/irinotecan and gemcitabine/irinotecan with or without celecoxib in the second-line treatment of non-small-cell lung cancer.
Cordectomy for the treatment of posttraumatic syringomyelia. Report of four cases and review of the literature.
Incorporate Language in Medical Education to Address Structural Barriers to Care During the COVID-19 Pandemic and Beyond.
Reduviidae
See All 24 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (39)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Faculty Rank
Name
Institution
Why
Leon Lenchik MD
Wake Forest School of Medicine
Why?
Ellen E. Quillen PhD
Wake Forest School of Medicine
Why?
Benjamin R. Graves MD
Wake Forest School of Medicine
Why?
Mariana Wingood
Wake Forest School of Medicine
Why?
Barry I. Freedman MD
Wake Forest School of Medicine
Why?
Cynthia L. Emory MD, MBA
Wake Forest School of Medicine
Why?
Christopher M. Gillette PhD
Wake Forest School of Medicine
Why?
Ashley A. Weaver PhD
Wake Forest School of Medicine
Why?
Susan E. Appt DVM
Wake Forest School of Medicine
Why?
Jeffrey S. Willey PhD
Wake Forest School of Medicine
Why?
J. M. Cline DVM, PhD
Wake Forest School of Medicine
Why?
Ronald L. Davis MD
Wake Forest School of Medicine
Why?
John G. Spangler MD
Wake Forest School of Medicine
Why?
Barbara A. Pisani DO, FACC, FAHA
Wake Forest School of Medicine
Why?
Julienne K. Kirk PharmD, BCPS
Wake Forest School of Medicine
Why?
Per Page
15
25
50
100
Page
of 3
Next
Prev
Search Criteria
Osteoporosis
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions